PUBG MOBILE
Mech Mania Showcase
SWEEPSTAKES OFFICIAL RULES
NO ENTRY FEE. NO PURCHASE OR OBLIGATION IS NECESSARY TO ENTER OR WIN. A PURCHASE WILL NOT IMPROVE THE CHANCES OF WINNING. ODDS OF WINNING WILL DEPEND ON THE TOTAL NUMBER OF ELIGIBLE ENTRIES RECEIVED WORLDWIDE. VOID WHERE PROHIBITED OR WHERE REGISTRATION, BONDING OR LOCALIZATION REQUIRED. SUBJECT TO ALL NATIONAL, REGIONAL AND LOCAL LAWS.
This Mech Mania Showcase (the “Sweepstakes”) is in connection with the video game PUBG MOBILE (the “Game”), and is governed by these official rules (“Official Rules”), the Game’s EULA available at https://www.pubgmobile.com/terms.html (“EULA”), the Game’s privacy policy available at https://pubgmobile.proximabeta.com/privacy/en.html (“Privacy Policy”), and any additional rules on the applicable Sweepstakes webpage. By submitting an entry to the Sweepstakes, you are accepting the terms and conditions of participation on the applicable Sweepstakes webpage, the Official Rules, the EULA, and the Privacy Policy.
The sponsor of this Sweepstakes is ZAM Network, LLC, a Delaware limited liability company with an office at 12777 W. Jefferson Blvd – Building E, Los Angeles, CA 90066 (“ZAM” or “Sponsor”).

1. Promotion Period

The Sweepstakes begins on May 21st at 12pm PDT and runs through June 3rd 2024 at 11:59pm PDT (the “Promotion Period”).

1. Eligibility

In order to be eligible, participants must be at least (whichever is higher): (i) 18 years old, or (ii) the age of majority in their state or country of their legal residence as of the date of entry, who have an active email account and Internet access. This Sweepstakes is not open to legal residents of Bangladesh, China, Colombia, Dubai, Egypt, Hong Kong, Indonesia, Italy, Malaysia, Mexico, Philippines, Quebec of Canada, Singapore, South Australia and QLD, South Korea, Turkey. Any additional eligibility requirements will be indicated in the additional terms found on the applicable Sweepstakes webpage. Persons identified as “Blocked Persons” or persons subject to applicable sanctions prohibitions, including, without limitation, those persons listed on the U.S. Department of Treasury Office of Foreign Assets Control’s Specially Designated Nationals and Blocked Persons List are not eligible to participate in the Sweepstakes. Employees of ZAM, Proxima Beta Pte. Ltd., Krafton, and their respective parent company, affiliates, subsidiaries, advertising, promotion, fulfillment or other coordinating agencies, individuals providing services to them through an outsourcer or temporary employment agency during the Promotion Period, and their respective immediate family members and persons living in the same household, are not eligible to participate in the Sweepstakes.

1. Entry Instructions

To participate in the Sweepstakes and be eligible for a potential prize, participants must complete one of the entry methods indicated on the applicable Sweepstakes webpage during the Promotion Period. One entry per individual, household and/or email address is permitted, regardless of method of entry, unless expressly set forth to the contrary in the additional terms found on the applicable Sweepstakes webpage. Multiple participants are not permitted to share the same email or other account needed for participation. Any attempt by any participant to obtain more than the stated number of entries by using multiple/different email or addresses, accounts, identities, registrations and logins, or any other methods will void that participant’s entries and that participant may be disqualified. Use of any automated, programmed or robotic system or the like entry methods to participate is prohibited and will result in disqualification. Each potential winner may be required to show proof of being the authorized account holder. All entries become property of ZAM and none will be acknowledged or returned.

Social Media Entry: Collect your best PUBG MOBILE content; then upload your content to social media with the hashtag #MECHMANIASHOWCASE + #SWEEPSTAKES. 

• Entries must be original and not violate any third-party rights, and the entrant must have all rights necessary to submit the entry.
• Entries may not contain material that (a) is obscene, defamatory, libelous, threatening, pornographic, racially or ethnically offensive, or encourages conduct that would be considered a criminal offense, give rise to civil liability, or violate any law; (b) infringes, misappropriates or violates a third party’s patent, copyright, trademark, trade secret, contractual rights, moral rights or other intellectual property rights, or rights of publicity or privacy, or any other rights of third parties; (c) violates, or encourages any conduct that would violate any applicable law or regulation or would give rise to civil liability; (d) is fraudulent, false, misleading or deceptive; (e) is grossly harmful, racially or ethnically objectionable, disparaging, blasphemous, libelous, defamatory, obscene, pornographic, pedophilic, vulgar or offensive; (f) promotes discrimination, bigotry, racism, hatred, harassment or harm against any individual or group; (g) is violent, bullying, or threatening or promotes violence, money laundering or gambling, terrorism, or actions that are threatening or disrespectful to any person or entity; (h) harms minors in any way; or (i) promotes illegal or harmful activities or substances.
• Entries must follow the community guidelines and terms of service of the social media platform used for entry (where applicable).
• Participants may enter any number of times, but are only eligible to win once per week during the Sweepstakes Period.
• Sponsor may reject any entries that are found, as determined by ZAM in its sole discretion, to be in violation of these Official Rules.

1. Drawing; Notification of Winners

All Sweepstakes entries meeting the requirements of these Official Rules will be entered into the prize drawing. The number of winners will be indicated in the additional terms found on the applicable Sweepstakes webpage. Each winner will be selected by a random-chance drawing by independent persons or a computer program that randomly chooses the winner, from all eligible entries received and the random selection is final and binding, subject to the below. ZAM will notify winners by email, U.S. Mail at the address associated with the winner’s entry form, and/or by other means consistent with the Sweepstakes as soon as reasonably practicable following the drawing, but at least within seven (7) days of the drawing. ZAM is not responsible for any delay or failure to receive notification, including inactive account(s), technical difficulties associated therewith, or winner’s failure to adequately monitor any account. The winner must then respond to ZAM within fourteen (14) days or such other time frame as may be specified on the applicable Sweepstakes webpage. Winner, and any guest (if applicable), may be required to sign an affidavit of eligibility and liability and publicity release. Should the winner fail to respond to ZAM or cannot be contacted, is ineligible, fails to claim a prize and/or where applicable an affidavit of eligibility and liability and publicity release is not timely received, is incomplete or modified, the prize may be forfeited and ZAM reserves the right to disqualify that winner and select a new one in a second-chance random drawing from remaining valid, eligible entries timely submitted.

1. Prize

Each winner will receive the prize below. No cash or other substitution, assignment or transfer of the prize is permitted, except at the sole option of ZAM, who has the right to substitute a prize with another of comparable or greater value. Winner is responsible for all income or other taxes and fees associated with the receipt and/or use of the prize. The odds of winning a prize depend on the total number of eligible entries received. ZAM will not replace any lost or stolen prizes. ZAM will use all reasonable efforts to deliver prizes in a timely fashion.
Prizes:
5 winners will each win UC valued at US$100

1. Intellectual Property
2. Ownership of the pre-existing underlying intellectual property of the entrant remains the property of the entrant subject to Sponsor’s rights to reprint, display, reproduce, perform, use, and exhibit the entry for the purpose of administering and promoting the Sweepstakes and for Sponsor’s marketing and advertising purposes. By participating in the Sweepstakes, each entrant grants to Sponsor a non-exclusive, worldwide, fully paid, royalty-free, perpetual, transferable license, with the right to sublicense, to reprint, display, reproduce, perform, use, and exhibit (including the right to make derivative works of) the entry and materials and information submitted on and in connection with the Sweepstakes or use or receipt of the prize for any and all purposes in any medium. If an entrant is selected as a winner, instead of the license granted above, each entrant grants to Sponsor an exclusive, worldwide, fully paid, royalty-free, perpetual, transferable license, with the right to sublicense, to reprint, display, reproduce, perform, use, and exhibit (including the right to make derivative works of) the entry and materials and information submitted on and in connection with the Sweepstakes or use or receipt of the prize for any and all purposes in any medium. Each participating entrant hereby warrants that any entry and other materials and information provided by entrant are original with entrant and do not violate or infringe upon the copyrights, trademarks, rights of privacy, publicity, moral rights or other intellectual property or other rights of any person or entity, and do not violate any applicable laws, rules or regulations. If the entry or information or materials provided by entrant contain any material or elements that are not owned by entrant and/or which are subject to the rights of third parties, entrant represents he or she has obtained, prior to submission of the entry and information or materials, any and all releases and consents necessary to permit use and exploitation of the entry, relevant information and materials by Sponsor in the manner set forth in these Official Rules without additional compensation.

Each entrant warrants that the entry and materials and information provided do not contain information considered by entrant, its employees or personnel, or any other third party to be confidential, and that the entry, materials and information provided do not violate any laws or regulations. Entrant agrees that Sponsor has the right to verify the ownership and originality of all entries and that, upon Sponsor’s request, entrant must submit a written copy of any release or permission entrant has received from a third-party granting entrant the right to use such property. Entrant understands and acknowledges that in the event a submission is selected as a winning entry, and entrant’s ownership, rights and the originality of the entry cannot be verified to the satisfaction of Sponsor or is in any other way ineligible, Sponsor may select an alternate winner based on the same judging criteria.

1. Except to the extent prohibited by law, entrants waive the benefit of any “moral rights” or “droit moral” or similar rights in any country to any content that they upload, submit or otherwise provide to Sponsor associated with the Sweepstakes (“Entrant Content”). In addition, when an entrant creates, appears in, uploads, or posts Entrant Content, that entrant grants Sponsor a non-exclusive, transferable, worldwide, royalty-free, unrestricted, perpetual, irrevocable, license, with the right to sublicense, to such entrant’s name, likeness, and voice, including in connection with commercial or sponsored content. This means, among other things, that such entrant will not be entitled to any compensation from Sponsor, its affiliates, or its business partners if such entrant’s name, likeness, or voice is conveyed through the game or any related services, or on one of Sponsor’s business partner’s platforms.
2. Disputes

In the event of a dispute as to any participant, the authorized account holder of the email address associated with the entry will be deemed to be the participant. The “authorized account holder” is the natural person assigned an email address by an Internet access provider, online service provider or other organization responsible for assigning email addresses for the domain associated with the submitted address. Each potential winner may be required to show proof of being the authorized account holder. ZAM will make final determination of identity of participants and timing of entries in its sole discretion.

1. Additional Conditions

ZAM reserves the right, in its sole discretion, to terminate, modify or suspend the Sweepstakes in whole or in part, if in ZAM’s opinion (a) the Sweepstakes is not capable of running as planned by reason of the occurrence of any event beyond its control including, but not limited to, fire, flood, epidemic, pandemic, earthquake, explosion, labor dispute or strike, act of God or public enemy, communications, equipment failure, utility or service interruptions, riot or civil disturbance, terrorist threat or activity, war (declared or undeclared), interference with the Sweepstakes by any party, or any federal, state, local or provincial government law, order, or regulation, order of any court or jurisdiction, or other cause not reasonably within ZAM’s control, or (b) any other factors beyond ZAM’s reasonable control corrupt or affect the administration, security, fairness, integrity, or proper conduct of the Sweepstakes, in all instances without liability to the participants. ZAM also reserves the right to disqualify any participant or winner, as determined by ZAM, in its sole discretion.

1. List of Winner(s)

Individuals may request the name of the winners by emailing Sponsor at entries@zam.com with the subject line: “Mech Mania Showcase Winners List”, within 90 days from the end of the Sweepstakes.

1. Personal Information

ZAM may collect personal data about participants online, in accordance with its privacy policy and as may be more specifically set forth in these Official Rules and the Privacy Policy.

1. Disclaimers and Limitations on Liability. ZAM MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, REGARDING ANY PRIZE OR YOUR PARTICIPATION IN THE SWEEPSTAKES. BY ENTERING THE SWEEPSTAKES OR RECEIPT OF ANY PRIZE, EACH ENTRANT AGREES TO RELEASE AND HOLD HARMLESS THE SWEEPSTAKES ENTITIES, ANY THIRD-PARTY SOCIAL MEDIA CHANNELS UTILIZED FOR THE SWEEPSTAKES, AND THEIR SUBSIDIARIES, AFFILIATES, SUPPLIERS, DISTRIBUTORS, ADVERTISING/SWEEPSTAKES AGENCIES, AND PRIZE SUPPLIERS, AND EACH OF THEIR RESPECTIVE PARENT COMPANIES AND EACH SUCH COMPANY’S OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS (COLLECTIVELY, THE “RELEASED PARTIES”) FROM AND AGAINST ANY CLAIM OR CAUSE OF ACTION, INCLUDING, BUT NOT LIMITED TO, PERSONAL INJURY, DEATH, OR DAMAGE TO OR LOSS OF PROPERTY, ARISING OUT OF PARTICIPATION IN THE SWEEPSTAKES OR RECEIPT OR USE OR MISUSE OF ANY PRIZE. THE RELEASED PARTIES ARE NOT RESPONSIBLE FOR: (1) ANY INCORRECT OR INACCURATE INFORMATION, WHETHER CAUSED BY ENTRANTS, PRINTING ERRORS OR BY ANY OF THE EQUIPMENT OR PROGRAMMING ASSOCIATED WITH OR UTILIZED IN THE SWEEPSTAKES; (2) TECHNICAL FAILURES OF ANY KIND, INCLUDING, BUT NOT LIMITED TO MALFUNCTIONS, INTERRUPTIONS, OR DISCONNECTIONS IN PHONE LINES OR NETWORK HARDWARE OR SOFTWARE; (3) UNAUTHORIZED HUMAN INTERVENTION IN ANY PART OF THE ENTRY PROCESS OR THE SWEEPSTAKES; (4) TECHNICAL OR HUMAN ERROR WHICH MAY OCCUR IN THE ADMINISTRATION OF THE SWEEPSTAKES OR THE PROCESSING OF ENTRIES; OR (5) ANY INJURY OR DAMAGE TO PERSONS OR PROPERTY WHICH MAY BE CAUSED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, FROM ENTRANT’S PARTICIPATION IN THE SWEEPSTAKES OR RECEIPT OR USE OR MISUSE OF ANY PRIZE. If for any reason an entrant's entry is confirmed to have been erroneously deleted, lost, or otherwise destroyed or corrupted, entrant’s sole remedy is another entry in the Sweepstakes, provided that if it is not possible to award another entry due to discontinuance of the Sweepstakes, or any part of it, for any reason, Sponsor, at its discretion, may elect to hold a random drawing from among all eligible entries received up to the date of discontinuance for any or all of the prizes offered herein. No more than the stated number of prizes will be awarded. In event that production, technical, programming or any other reasons cause more than stated number of prizes as set forth in these Official Rules to be available and/or claimed, Sponsor reserves the right to award only the stated number of prizes by a choosing from all legitimate, unawarded, eligible prize claims. In the event Sponsor is prevented from continuing with the Sweepstakes as contemplated herein by any event beyond its control, including but not limited to fire, flood, earthquake, explosion, labor dispute or strike, act of God or public enemy, or any federal, state or local government law, order, or regulation, or other cause not reasonably within Sponsor’s control (each a "Force Majeure" event or occurrence), then subject to any governmental approval which may be required, Sponsor shall have the right to modify, suspend, or terminate the Sweepstakes. The invalidity or unenforceability of any provision of these rules shall not affect the validity or enforceability of any other provision.
2. Indemnification

You agree to release, indemnify, defend and hold ZAM and its parent, affiliates, subsidiaries, directors, officers, employees, sponsors and agents, including advertising and promotion agencies, and assigns, and any other organizations related to the Sweepstakes, harmless, from any and all claims, injuries, damages, expenses or losses to person or property and/or liabilities of any nature that in any way arise from participation in the Sweepstakes or acceptance or use of a prize or parts thereof, including, without limitation, (a) any condition caused by events beyond ZAM’s control that may cause the Sweepstakes to be disrupted or corrupted; (b) the prize, or acceptance, possession, or use of the prize, or from participation in the Sweepstakes; and (c) any printing or typographical errors in any materials associated with the Sweepstakes.

1. Publicity

Except where prohibited, by participating in the Sweepstakes, you consent to the use of your name, photograph, likeness, voice, opinions, information, biographical information, entry and statements attributed to you (if true), hometown and jurisdiction of residence for advertising, publicity and promotional purposes, including without limitation, inclusion in ZAM’s newsletters, social media accounts and affiliated websites and the applicable Sweepstakes webpage, without further compensation.

1. Governing Law

These Official Rules, and any action related thereto, will be governed by the Federal Arbitration Act, federal arbitration law and the laws of the State of California without regard to conflict of laws provisions. Except as otherwise expressly set forth in Section 15 “Dispute Resolution and Arbitration” the exclusive jurisdiction for all Disputes (defined below) that you and ZAM are not required to arbitrate will be the state and federal courts located in Los Angeles County, California and you and ZAM each waive any objection to jurisdiction and venue in such courts.

1. Dispute Resolution and Arbitration
   
2. Mandatory Arbitration of Disputes. We each agree that any dispute, claim or controversy arising out of or relating to these Official Rules or the breach, termination, enforcement, interpretation or validity thereof or participation in the Sweepstakes (collectively, “Disputes”) will be resolved solely by binding, individual arbitration and not in a class, representative or consolidated action or proceeding. You and ZAM agree that the U.S. Federal Arbitration Act governs the interpretation and enforcement of these Official Rules, and that you and ZAM are each waiving the right to a trial by jury or to participate in a class action. This arbitration provision shall survive termination of these Official Rules.
   
3. Exceptions. As limited exceptions to Section 15(a) above: (i) we both may seek to resolve a Dispute in small claims court if it qualifies; and (ii) we each retain the right to seek injunctive or other equitable relief from a court to prevent (or enjoin) the infringement or misappropriation of our intellectual property rights.
   
4. Conducting Arbitration and Arbitration Rules. The arbitration will be conducted by the American Arbitration Association (“AAA”) under its Consumer Arbitration Rules (the “AAA Rules”) then in effect, except as modified by these Official Rules. The AAA Rules are available at www.adr.org or by calling 1-800-778-7879. A party who wishes to start arbitration must submit a written Demand for Arbitration to AAA and give notice to the other party as specified in the AAA Rules. The AAA provides a form Demand for Arbitration at www.adr.org. Any arbitration hearings will take place in the county (or parish) where you live, unless we both agree to a different location. The parties agree that the arbitrator shall have exclusive authority to decide all issues relating to the interpretation, applicability, enforceability and scope of this arbitration agreement.
   
5. Arbitration Costs. Payment of all filing, administration and arbitrator fees will be governed by the AAA Rules, and we won’t seek to recover the administration and arbitrator fees we are responsible for paying, unless the arbitrator finds your Dispute frivolous. If we prevail in arbitration we’ll pay all of our attorneys’ fees and costs and won’t seek to recover them from you. If you prevail in arbitration you will be entitled to an award of attorneys’ fees and expenses to the extent provided under applicable law.
   
6. Injunctive and Declaratory Relief. Except as provided in 13(b) above, the arbitrator shall determine all issues of liability on the merits of any claim asserted by either party and may award declaratory or injunctive relief only in favor of the individual party seeking relief and only to the extent necessary to provide relief warranted by that party’s individual claim. To the extent that you or we prevail on a claim and seek public injunctive relief (that is, injunctive relief that has the primary purpose and effect of prohibiting unlawful acts that threaten future injury to the public), the entitlement to and extent of such relief must be litigated in a civil court of competent jurisdiction and not in arbitration. The parties agree that litigation of any issues of public injunctive relief shall be stayed pending the outcome of the merits of any individual claims in arbitration.
   
7. Class Action Waiver. YOU AND ZAM AGREE THAT EACH MAY BRING CLAIMS AGAINST THE OTHER ONLY IN YOUR OR ITS INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS OR REPRESENTATIVE PROCEEDING. Further, if the parties’ Dispute is resolved through arbitration, the arbitrator may not consolidate another person’s claims with your claims, and may not otherwise preside over any form of a representative or class proceeding. If this specific provision is found to be unenforceable, then the entirety of this Dispute Resolution and Arbitration section shall be null and void.
   
8. Severability. With the exception of any of the provisions in Section 15(f) (“Class Action Waiver”), if an arbitrator or court of competent jurisdiction decides that any part of these Official Rules is invalid or unenforceable, the other parts of these Official Rules will still apply.
   
9. Languages. These Official Rules may be made in multiple language versions. In the event of a dispute as to the terms of different language versions, the English version shall prevail.
   
10. Country Specific Notices.
    
11. If any provision of these Official Rules is invalid under the law, rules, or regulations of a particular country, it will only apply to the extent permitted.
    
12. No Affiliation with Social Media Channels.
    
13. This Sweepstakes is in no way sponsored, endorsed, or administered by, or associated with, any of the social media channels used in connection with this Contest. Entrants understand that entrants are providing information to Sponsor and not to the social media channels. The information provided by entrants will only be used as described in these Official Rules and the Game’s Privacy Policy.
    

For any feedback or questions regarding these Official Rules, the Sweepstakes, winners, or prizes, you can contact Sponsor by sending an email to: entries@zam.com

I interact daily with a lot of people within and outside of the "AI world." A glaring 80% have no idea that Anthropic even exists. The remaining 20% is convinced that all "Claude.ai" has to offer is Sonnet.
They go to the web chat, create an account, try a few prompts with the free models, and decide that's more or less ChatGPT 3.5/4 level so doesn't worth a subscription. They have never heard of Opus, or the fact that "Claude 3" is a family of models with very different capabilities. Even professors and software engineers.
I think that the fact that Opus is behind a paywall and there's no trial whatsoever, and it's not advertised, is keeping a lot of people away. Sonnet is good for many tasks but absolutely not on par with Opus, with what Anthropic really has to offer.
I think you would benefit immensely from giving general public at least some free prompts with your flagship model, and maybe post way more demos spanning a lot of use cases that might be of interest (and generally better advertising for the company.) Please give them the opportunity to know you, really know you. You deserve it.

DAY: MAY 20 2024
5-20-2024

Why nightmares and ‘daymares’ could be early warning signs of autoimmune disease

An increase in nightmares and hallucinations—or ‘daymares’—could herald the onset of autoimmune diseases such as lupus, say an international team led by researchers at the University of Cambridge and King’s College London. The researchers argue that there must be greater recognition that these types of mental health and neurological symptoms can act as an early warning sign that an individual is approaching a “flare,” where their disease worsens for a period.
5-20-2024 Yoga and meditation-induced altered states of consciousness are common in the general population, study says
Yoga, mindfulness, meditation, breathwork, and other practices are gaining in popularity due to their potential to improve health and well-being. The effects of these practices are mostly positive and occasionally transformational, yet they are known to sometimes be associated with challenging altered states of consciousness. New research by a team including investigators from Massachusetts General Hospital reveals that altered states of consciousness associated with meditation practice are far more common than expected. Although many people reported positive outcomes, that were sometimes even considered transformational, from these experiences, for a substantial
5-20-2024 Examining the benefits of out-of-network care for pediatric moyamoya
Total in-episode expenses and resource use before the index surgery (preop) and including/after the surgery (postop). The comparisons are separated for analysis into (A) single institution cohorts (1 and 2) and (B) multi?institution cohorts (3 and 4). Moyamoya disease is a rare condition that affects the blood vessels in the brain, especially in children. Narrowing and blockage of vessels significantly increases the risk of stroke and requires surgical revascularization for treatment. Although research shows that outcomes of revascularization are better
5-20-2024 Study explores links between social media use, mental health and sleep quality
The more time you spend on social media, the greater the likelihood of having unpleasant social-media related dreams that cause distress, sleep disruption and impact our peace of mind. Flinders University’s Reza Shabahang says that the vast and rapid adoption of social media has the potential to influence various aspects of life, including the realm of dreaming. “As social media becomes increasingly intertwined with our lives, its impact extends beyond waking hours, and may influence our dreams,”
5-20-2024 How are asthma and heart health linked?
Although the heart and lungs are neighbors in your chest, people may think of them as separate entities with unrelated problems. But a growing body of evidence suggests that asthma—one of the most common lung disorders—is a risk factor for cardiovascular disease. Asthma is a serious chronic disease in which airways are inflamed, often in response to specific triggers. It affects about 25 million people in the U.S., including nearly 5 million children, causing millions of annual visits to doctors’ offices and emergency rooms. “We call these major changes
5-20-2024 STUDY EXPLORES PATIENT TRUST IN PHYSICIANS
Trust in one’s physician drives positive health practices. In a scoping review, SUNY Poly Professor of Sociology Dr. Linda R. Weber discovered new developments in the measurement of trust, identified those measures of trust that have known reliability and validity, and compared those instruments’ conceptualizations, dimensions, and indicators. The paper is published in the journal PLOS ONE. Weber explains that 10 dimensions emerged from the study: fidelity, technical competence, communicative competence, interpersonal competence (i.e., caring), honesty, confidentiality, global, behavioral, fairness, and system trust/accountability. In addition, these findings provide the foundation
5-20-2024 TIMESAVING TIPS FOR COOKING HEALTHY MEALS
Living a busy, fast-paced life can make it hard to find the motivation to cook a healthy meal at home. However, learning some shortcuts in the kitchen can keep your healthy eating goals on track and help you avoid grazing on unhealthy snacks, grabbing the first thing you see in the fridge or going out for fast food. Why cook at home? Research shows that maintaining a healthy weight is challenging when you eat out too frequently. Restaurant portions often are super-sized
5-20-2024 UNDERSTANDING PERIMENOPAUSE VS. MENOPAUSE
Menopause marks a significant transition for women, yet understanding its precursor, perimenopause, and its symptoms can be complex. Dr. Stephanie Faubion, director of Mayo Clinic’s Center for Women’s Health and medical director of The Menopause Society, says experiencing perimenopause and menopause can be confusing for some. She says it is not only patients who may find it confusing, but medical providers as well, due to lack of training in menopause management. “Menopause is defined by no menstrual cycle for a year,” says Dr. Faubion.
5-20-2024 LOW-DOSE IRON SUPPLEMENTATION HAS NO BENEFIT FOR BREASTFED INFANTS, SHOWS STUDY
The American Pediatric Association recommends iron supplements to all healthy infants who breastfeed longer than four months, while its European counterpart, Society of Gastroenterology, Hepataology and Nutrition, does not recommend it. These deviating guidelines stimulated researchers to design a new study. Breastfeeding is strongly recommended, and the proportion of children are breastfed during the first half of life is high. The researchers wanted to determine whether breastfeeding babies could benefit from extra iron.
5-20-2024 ALLERGY MEDICATIONS COME WITH HAZARDS: BE AWARE
People with seasonal allergies often turn to over-the-counter and prescription medicines to relieve symptoms like coughing, sneezing, runny nose, congestion and itchy eyes, nose or throat. But they often aren’t aware that these meds—including antihistamines—have as much risk for potential side effects, drug interactions and overdose as other drugs. “All medicines have side effects associated with them even when they are taken appropriately and according to dosing directions on the label,”
5-20-2024 I CAN’T AFFORD OLIVE OIL—WHAT ELSE CAN I USE?
If you buy your olive oil in bulk, you’ve likely been in for a shock in recent weeks. Major supermarkets have been selling olive oil for up to A$65 for a four-liter tin, and up to $26 for a 750 milliliter bottle. We’ve been hearing about the health benefits of olive oil for years. And many of us are adding it to salads, or baking and frying with it. But during a cost-of-living crisis, these high prices can put olive oil out of reach. Let’s take a look at why
5-20-2024 Researchers uncover biological trigger of early puberty
Heather Brenhouse, associate professor of psychology, says disrupting the caretaker relationship can really traumatize a child or a developing rodent. Credit: Ruby Wallau/Northeastern University New research conducted by the Brenhouse Lab reveals how early life adversity triggers early puberty and late-life anxiety, paving the way for potential interventions. The onset of puberty has been creeping downward for decades. In the United States, the average age of girls reaching puberty ranges from 8.8 to 10.3 years old. The early start of puberty, which is associated with many health risks, can be
5-20-2024 Bioluminescence and 3D-printed implants shed light on brain–spinal interactions
Brain-spinal cord duet’s neurodynamic symphony is now accessible to scientists via novel multi-organ implants. Credit: Dmitrijs Celinskis A sensory process such as pain is no ordinary phenomenon—it’s a symphony of neural and vascular interactions orchestrated by the brain and spinal cord. Attempting to dissect this symphony by focusing on a single region is like trying to understand a complex melody by listening to just one instrument. It’s incomplete, potentially misleading, and may result in erroneous conclusions. Enter the Carney Institute’s team of visionaries. Their mission? To develop tools that allow
5-20-2024 New thesis explores cancer treatment that can prevent relapse
. What is the main focus of your thesis? Relapse following initial treatment efficacy remains a major clinical challenge for many cancers. The focus of my thesis has been to explore the therapeutic impact of immune cells in patients with blood cancer (leukemia), by first investigating which cells
5-20-2024 New study reveals health and social benefits of car-free living
Participating in a three-week car-free challenge has enhanced the health and well-being of Oxford residents, according to research conducted by The University of Bath’s Centre for Climate Change and Social Transformations (CAST), in partnership with climate charity Possible and Low Carbon Oxford North (LCON), conducted this research project. After ditching their cars for three weeks, 10 out of the 12 drivers across Oxford who participated said they plan to continue with reduced car use beyond the project. The findings of this research project show that: Day-to-day transport emissions were slashed
5-20-2024 Research shows linked biological pathways driving skin inflammation
A certain biological pathway—a set of linked reactions in the body—drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all inflammatory skin diseases, including atopic and allergic dermatitis and a type of boil called hidradenitis suppurativa, say the study authors. The findings are published in the journal Immunity. Inflammation is the body’s natural response to irritation and infection, but when out of control, it can lead to the reddish, flaky, itchy lesions that
5-20-2024 Prescription co-payments linked to more hospital admissions in New Zealand, study finds
A new study from researchers cautions that bringing back the $5 co-payment for prescription medicines could see a jump in hospital admissions. The study analyzed health data for 71,502 people and found those who didn’t pick up a prescription because they couldn’t afford the $5 fee had a 34% higher rate of being admitted to hospital.
5-20-2024 How a simulation is informing COVID-19 vaccine policy after our ‘return to normal’
As the saying goes “There is no such thing as normal” and this has been especially true after the pandemic. Before the emergence of the omicron COVID-19 variant, countries like the U.K. had high vaccination coverage along with widespread exposure to COVID-19 in the population. This combination of vaccine and infection-derived immunity is termed hybrid immunity and is different to vaccine immunity or infection immunity alone. In contrast, other countries, including Australia, New Zealand and those in the Western Pacific, had a very different pandemic experience.
5-20-2024 Researchers find intriguing connections between Alzheimer’s disease and other common conditions
A study has found that while some medical conditions appear to increase our likelihood of developing Alzheimer’s disease, others appear to decrease the odds. The study, led by Dr. Yijun (Nicholas) Pan and Dr. Liang Jin, analyzed data from 2,443 older Australians living in Melbourne or Perth who are part of the Australian Imaging, Biomarker and Lifestyle (AIBL) study, an internationally recognized cohort for dementia research. “We found anxiety and other neurological disorders are associated with increased likelihood of Alzheimer’s disease,” Dr. Pan said.
5-20-2024 Prepping autistic or sound-sensitive kids for cicada noise
As Chicagoans await the emergence of the cicadas, parents of children on the autism spectrum and/or who have sensitivities to sound can take a few steps to prepare for what is expected to be a loud summer. “Some children on the spectrum can struggle with loud or unexpected noises, such as toilets that automatically flush, fireworks around the Fourth of July or the emergence of a large number of cicadas,”
5-20-2024 Study highlights importance of screening for rare inherited iron metabolism defects
Over 40% of cases curated based on stringent clinical and laboratory criteria from the Indian subcontinent have an inherited iron metabolism defect on comprehensive genomic evaluation, report investigators in The Journal of Molecular Diagnostics. Although iron deficiency anemia is the most prevalent form of anemia globally,
5-20-2024 Study finds tyrosine kinase Csk promotes germinal center B cell survival and affinity maturation
The authors found that Csk (a tyrosine kinase that attenuates B cell receptor signaling) is required for germinal center maintenance and efficient antibody maturation. The immune system strikes a fine balance by identifying and neutralizing disease-causing agents while carefully avoiding destruction of healthy tissues and cells. Now, researchers from Japan have shed new light on one of the processes that helps train immune cells to act only against genuine threats.
5-20-2024 Significant gaps between science of obesity and the care patients receive, say experts
As research continues to produce evidence about the underlying causes of obesity and optimal strategies to treat and manage obesity have evolved, there are disparities in application of the latest scientific advances in the clinical care that people with obesity receive. Widespread adoption of current findings, consistency of care and expertise in obesity care varies by health care professional and institution.
5-20-2024 Improving online depression treatment
Symptom course of depression for individuals who dropped out of treatment and those who completed treatment. In the dropout group, there is an initial decrease in symptoms while the patients were still in treatment, which tapers off as they drop out. For completers, there is close to a linear change over time. This suggests there is a relation between the more that an individual continues to participate in ICBT and their depressive symptom improvement.
5-20-2024 Women face worse chronic kidney disease management in primary care
Women receive worse primary care-based chronic kidney disease (CKD) management than men, according to a research letter adult patients with CKD receiving primary care at 15 practices using electronic health record data to examine sex disparities in guideline-based CKD management
5-20-2024 Bisoprolol does not reduce exacerbations in at-risk COPD patients
For patients with chronic obstructive pulmonary disease (COPD), bisoprolol does not reduce the number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both, according to a study
5-20-2024 Anticancer potential of CLK kinase inhibitors 1C8 and GPS167 via EMT and antiviral immune response
The diheteroarylamide-based compound 1C8 and the aminothiazole carboxamide-related compound GPS167 inhibit the CLK kinases, and affect the proliferation of a broad range of cancer cell lines. A chemogenomic screen previously performed with GPS167 revealed that the depletion of components associated with mitotic spindle assembly altered
5-20-2024 Study sheds light on bacteria associated with pre-term birth
Researchers from North Carolina State University have found that multiple species of Gardnerella, bacteria sometimes associated with bacterial vaginosis (BV) and pre-term birth, can coexist in the same vaginal microbiome. The findings, published in mSystems, add to the emerging picture of Gardnerella’s effects on human health. Gardnerella is a group of anaerobic bacteria that are commonly found in the vaginal microbiome. Higher levels of the bacteria are a signature of BV and associated with higher risk of pre-term birth, but it is also found in women who have no sign
5-20-2024 New AI model uses federated learning for multi-organ segmentation based on medical image data
Researchers have successfully developed the technology that can accurately segment different body organs by effectively learning medical image data used for different purposes in different hospitals, which is expected to greatly contribute to the development of large-scale medical AI models in the future.
5-20-2024 Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug—dupilumab—that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine. This monoclonal antibody is the first biologic shown to improve clinical outcomes in COPD. The data supporting the use of dupilumab in COPD will be reviewed by the United States Food and Drug Administration in June. The disease improvements—as measured by a significantly lower annualized rate of acute exacerbations
5-20-2024 New AI model uses federated learning for multi-organ segmentation based on medical image data
Researchers have successfully developed the technology that can accurately segment different body organs by effectively learning medical image data used for different purposes in different hospitals, which is expected to greatly contribute to the development of large-scale medical AI models in the future.
5-20-2024 Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with type 2 inflammation
Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug—dupilumab—that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine. This monoclonal antibody is the first biologic shown to improve clinical outcomes in COPD. The data supporting the use of dupilumab in COPD will be reviewed by the United States Food and Drug Administration in June. The disease improvements—as measured by a significantly lower annualized rate of acute exacerbations

• 5-20-2024GALLBLADDER CANCER RISES AMONG BLACK AMERICANS AS CASES DECLINE IN OTHER GROUPS
• 5-20-2024US PEDIATRICIANS REVERSE DECADES-OLD ADVICE AGAINST HIV-POSITIVE MOTHERS BREASTFEEDING
• 5-20-2024UK REPORT FINDS COVER-UP OF DECADES-LONG INFECTED BLOOD SCANDAL
• 5-20-2024ASTRAZENECA TO BUILD $1.5 BLN CANCER DRUG FACILITY IN SINGAPORE
• 5-20-2024CHEMO FOR GLIOBLASTOMA ENHANCED BY TAPPING INTO CELL’S DAILY RHYTHMS
• 5-20-2024RESEARCH SHOWS THAT FERROPTOSIS, A FORM OF CELL DEATH, OCCURS IN SEVERE COVID-19 PATIENT LUNGS
• 5-20-2024BODY’S ‘MESSAGE IN A BOTTLE’ DELIVERS TARGETED CANCER TREATMENT
• 5-20-2024EARLY BLOOD GLUCOSE CONTROL FOR THOSE WITH TYPE 2 DIABETES CRUCIAL FOR REDUCING COMPLICATIONS, PROLONGING LIFE
• 5-20-2024GRID CELL RESPONSES TO THE ILLUSION OF SELF-LOCATION
• 5-20-2024RESEARCHERS DISCOVER TOP-DOWN SIGNALS IN BRAIN CIRCUITS REGULATING DEPRESSION
• 5-20-2024BENIGN NAIL CONDITION LINKED TO RARE SYNDROME THAT GREATLY INCREASES CANCER RISK
• 5-20-2024RESEARCHERS REVEAL PROMISING TREATMENT TARGET FOR RESISTANT BRAIN CANCER
• 5-20-2024NEW MECHANISMS UNDERLYING TUMOR VARIETY IN BRAIN CANCERS DISCOVERED
• 5-20-2024STUDY EXPLORES PATIENT TRUST IN PHYSICIANS
• 5-20-2024MOTIVATED BY LACK OF DIVERSITY IN NEUROLOGICAL STUDIES, SCIENTISTS LOOK TO ENSURE EQUITY IN BRAIN RESEARCH
• 5-20-2024FLUORIDE EXPOSURE DURING PREGNANCY LINKED TO INCREASED RISK OF CHILDHOOD NEUROBEHAVIORAL PROBLEMS, STUDY FINDS
• 5-20-2024STUDY SUGGESTS BOTH STEP AND TIME-BASED EXERCISE TARGETS ARE EQUALLY BENEFICIAL
• 5-20-2024MEDICAID ‘UNWINDING’ DECRIED AS BIASED AGAINST DISABLED PEOPLE
• 5-20-2024TIMESAVING TIPS FOR COOKING HEALTHY MEALS
• 5-20-2024UNDERSTANDING PERIMENOPAUSE VS. MENOPAUSE
• 5-20-2024LOW-DOSE IRON SUPPLEMENTATION HAS NO BENEFIT FOR BREASTFED INFANTS, SHOWS STUDY
• 5-20-2024IS IT BIRD FLU JUST AN ANIMAL THING, OR CAN PEOPLE CATCH IT?
• 5-20-2024SCIENTISTS USE NEW APPROACH TO DISABLE BRAIN CANCER CELLS’ ABILITY TO SURVIVE
• 5-20-2024RESEARCHER FINDS MOTHERS LIVE LONGER AS CHILD MORTALITY DECLINES
• 5-20-2024U-SHAPED LINK DETECTED BETWEEN ADOLESCENT BMI AND MENTAL HEALTH
• 5-20-2024AI CHATBOTS SHOW HIGHER EMPATHY, READABILITY IN RESPONDING TO CANCER QUESTIONS, STUDY FINDS
• 5-20-2024ALLERGY MEDICATIONS COME WITH HAZARDS: BE AWARE
• 5-20-2024GENETICALLY ENGINEERED PIG HEARTS TRANSPLANTED IN TWO BRAIN-DEAD PATIENTS REVEAL MORE ABOUT IMMUNE RESPONSE
• 5-20-2024I CAN’T AFFORD OLIVE OIL—WHAT ELSE CAN I USE?
• 5-20-2024HOW NEWBORN CHICKS ARE HELPING TO SETTLE A CENTURIES-OLD DEBATE ABOUT COGNITION AND OUR SENSES
• 5-20-2024STOMACH PARALYSIS RISK MAY RISE IN PEOPLE TAKING OZEMPIC AND SIMILAR DRUGS
• 5-20-2024WHY AUTISTIC PEOPLE MUST BE AT THE HEART OF AUTISM RESEARCH
• 5-20-2024OUR BODIES DON’T JUST MAKE GALL AND KIDNEY STONES—FROM SALIVA TO TONSILS, THESE ARE OTHER ONES TO LOOK OUT FOR
• 5-20-20241 IN 4 PARENTS SAY THEIR TEEN CONSUMES CAFFEINE DAILY OR NEARLY EVERY DAY
• 5-20-2024EX-CIGARETTE SMOKERS WHO VAPE MAY BE AT HIGHER RISK FOR LUNG CANCER
• 5-20-2024DOING DAILY CHORES AROUND THE HOUSE IS BEST ACTIVITY FOR INDIVIDUALS RECOVERING FROM COVID-19, SAY SCIENTISTS
• 5-20-2024NEW AI ALGORITHM MAY IMPROVE AUTOIMMUNE DISEASE PREDICTION AND THERAPIES
• 5-20-2024ALCOHOL USE DISORDER CAN BE TREATED WITH AN ARRAY OF MEDICATIONS—BUT FEW PEOPLE HAVE HEARD OF THEM
• 5-20-2024VITAMIN D DEFICIENCY TIED TO WORSE OUTCOMES WITH EARLY KIDNEY DISEASE
• 5-20-2024NEGATIVE LINK SEEN FOR OXIDATIVE BALANCE SCORE WITH CHRONIC KIDNEY DISEASE
• 5-20-2024ANDEXANET YIELDS BETTER CONTROL OF HEMATOMA EXPANSION THAN USUAL CARE, FINDS STUDY
• 5-20-2024STUDY FINDS FAT CELLS INFLUENCE HEART HEALTH IN CHAGAS DISEASE
• 5-20-2024PEDIATRICIAN EXPLAINS WHY INFANTS NEED BABY FORMULA INSTEAD OF COW’S MILK
• 5-20-2024HOW TELEHEALTH HAS IMPROVED THE LIVES OF PEOPLE WITH SUBSTANCE DISORDERS
• 5-20-2024RESEARCHERS DEVELOP FIRST HUMAN MINI-BRAIN WITH FULLY FUNCTIONAL BLOOD-BRAIN BARRIER
• 5-20-2024FROM INFECTION TO CHRONIC ILLNESS: LEARNING FROM LONG COVID
• 5-20-2024PLATELET BIOMARKERS SHED LIGHT ON POTENTIAL RISK FACTORS FOR SUDDEN INFANT DEATH SYNDROME
• 5-20-2024DO PATIENTS WITH DEVICE-DETECTED ATRIAL FIBRILLATION AND PRIOR STROKE BENEFIT FROM ANTICOAGULATION?
• 5-20-2024CONTRACEPTION OPTIONS SHOULD BE GIVEN WITH ORAL RETINOIDS TO AVOID SERIOUS HARM TO UNBORN BABIES, SAYS STUDY
• 5-20-2024STUDY REVEALS INEQUITIES IN MENTAL HEALTH SERVICES FOR JUSTICE-INVOLVED YOUTH AS THEY AGE
• 5-20-2024STUDY SHOWS EXERCISE SPURS NEURON GROWTH AND REWIRES THE BRAIN, HELPING MICE FORGET TRAUMATIC AND ADDICTIVE MEMORIES
• 5-20-2024RESEARCHERS DISCOVER BRAIN NETWORK THAT RECOGNIZES EMOTIONS
• 5-20-2024PHILLY HEALTH OFFICIALS DETECT A VETERINARY SEDATIVE MORE POWERFUL THAN XYLAZINE IN DRUG SAMPLES
• 5-20-2024PARC MODEL OF CARE ASSOCIATED WITH FEWER DEATHS AMONG VETERANS POST-ICU
• 5-20-2024CAR-T THERAPY IN PEDIATRIC LEUKEMIA
• 5-20-2024SPIROMETRY CLINICAL TRIAL ELIGIBILITY MAY DIFFER WITH RACE-NEUTRAL EQUATIONS
• 5-20-2024CAN PINK NOISE ENHANCE SLEEP AND MEMORY? EARLY RESEARCH DRIVES A COLOR NOISE BUZZ
• 5-20-2024NEW CRISPR SCREENING METHOD COULD REVEAL WHAT DRIVES BRAIN DISEASES
• 5-20-2024IS A GLOBAL PANDEMIC PREVENTION PACT WITHIN REACH?
• 5-20-2024NEW DEVICE HELPS PARAPLEGICS REGAIN PARTIAL USE OF HANDS
• 5-20-2024RELATIONSHIP STUDY SAYS PARENTAL ACCEPTANCE IN CHILDHOOD PREDICTS ABILITY TO FORGIVE AS ADULTS
• 5-20-2024SIMULATION-BASED TRAINING PROGRAM IMPROVES EVALUATION OF UNDESCENDED TESTICLES
• 5-20-2024UPTAKE OF FLU, WHOOPING COUGH, AND COVID-19 VACCINES REMAINS LOW AMONG PREGNANT WOMEN
• 5-20-2024NEW TOOL FLAGS HIDDEN SEXUAL STRUGGLES IN FEMALE PARTNERS OF PATIENTS WITH PROSTATE CANCER

Few days back, I was using adobe acrobat pro to open pdf and to edit, I used their free trial option. after filling my credentials, when I tried to use the edit option, it showed that they are installing the additional features. I ended up not using it because after that I closed acrobat, but when I opened it the second day, it would take me straight to subscription option even though I already had the free trial. I ended up deleting and downloading adobe again. I signed using my Apple ID and then went to settings to cancel my subscription because I don’t wanna be charged. There it showed that I had no plans. I checked again like any subscriptions in my settings and all that . I got charged today and don’t know what to do to cancel it. Please helpppp!

As a preface I want to ask the mods to please read through this and thoroughly think it over before deciding to lock or remove this thread. This is not a BS thread of me trying to sell anything, mislead anyone, or do anything for personal gain. What follows is a limited outline of my research from the last 3 years that I feel would be beneficial and give bettors new insight and perspective into sports betting.

 

Here is a controversial statement: Several, not all, sports can be accurately predicted. Through one very simple algorithm that can be seen in a movie, statistics that are available for free online, a basic understanding of mathematical constants, and an open mind to challenge something we have not seen done before, I am about to soft reveal how the way we view the prediction of outcomes should be changed.

 
Today we will cover Soccer, WNBA & NBA. At the time of writing this there are MLB games going on so compiling MLB data with my schedule tomorrow will be hard to get my pick in this thread so we will primarily cover Soccer and Basketball now.
 
With soccer I decided to only look at passing & possession stats. I then deployed the algorithm and made 4 more statistics that divide, multiply, add, subtract, etc a combination of the numbers, algorithms and custom numbers I compiled. I use this to read and determine which team with score first.
 
With Basketball I determined that it is best to track advanced assist & shooting percentage numbers. After trial and error, I then found a sweet spot combo of stats I deployed the algorithm and again began making my own custom stats. With basketball is where we need basic understanding of mathematical constants where there is a single threshold (aka if a certain number I create falls below the threshold, then it will cause me to choose option 1 to make my pick, this is less common. If the number is above the threshold, then I use option 2, the easiest, to make the pick) the pick is then made and I know the outcome.
 
Baseball is my baby, my bastard, the thing that has caused me to lose sleep and question my sanity, the SOB that began the whole project in 2019. She’s a hateful beast that has been the equivalent of wrestling a pissed off crocodile whereas the others required as much work as a jog through the park. I dislike baseball, I don’t watch it. 5 years ago, I could tell you tons of active obscure players, I enjoyed the games no one else cared about, I enjoyed the storylines, etc. but this project has since permanently altered my love and care for the sport. I worked 7 days a week on this project, which has of course taken several different twists and turns as to what I felt like I was doing or sat out to do (which was to win DFS) I took an entire year and half off from 2021-2022 to come back and tackle it. It didn’t work then. I took the back half of 2023 off and spot worked here and there when life was getting me down. I made several leaps and bounds and came with experience and new perspective each time but each time I felt like the closer I got to the goal it was only waiting to be yanked away. I decided for the final time in March 2024 to give it one last try and damn it I got it. This is my Magnum Opus; I don’t care what challenges I face professionally or personally; this was the loch ness monster I sat out to find. Was it worth it? I don’t know. It’s aged me. I knew deep in my serotonin deprived brain that Baseball could be predicted but here are so many moving parts and factors that must be accounted for. New stats must be made to make sense of everything. It’s still challenging and there are games that are in obscure land that I can’t confidentially make predictions on which is the loss I have no other option but to accept. However, there are several I can. For baseball we begin making a stat that includes contact (Out of Zone and Zone contact made with the ball), we also incorporate Swing/Strike percentage, and the pLI (player leverage index)

 
But enough about me, let’s lay out the winners for May 21, 2024 as written just before midnight on May 20, 2024
Boston takes Game 1 against Indiana (wow shocker a heavy favorite win, ok let’s go further)
Atlanta Dream beats the Dallas Wings in the WNBA (ATL is 5.5 point favorite)
Washington Mystics beat the LA Sparks in the WNBA (LA is 3.5 point favorite)
Minnesota takes Game 1 against Dallas on 5/22 (this one is kind of interesting because of a rare mathematical constant situation paired from both teams that has popped up for a unique situation that has not been found in over 2,000 games sampled. If I were betting, I would skip this one simply because there is no history to make a full logical determination that Minnesota would win. But I haven’t come this far to lay down over a technicality. I still say Minnesota)
On May 24 Girona will score the first goal against Granada
 

This isn’t luck, this isn’t a heater, this isn’t a guess, this isn’t 80% accuracy. This is real.